Asparagus racemosus ameliorates cisplatin induced toxicities and augments its antileishmanial activity by immunomodulation in vivo

Parasitology International

Volumn 63, Issue 1, 2014, Pages 21-30

  Sachdeva, Heena ^a   Sehgal, Rakesh ^b   Kaur, Sukhbir ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Asparagus racemosus; Cisplatin; Immunomodulatory; Leishmania donovani; Treatment; Visceral leishmaniasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTILEISHMANIAL AGENT; ASPARAGUS RACEMOSUS EXTRACT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; CREATININE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LIVER PROTECTIVE AGENT; UREA; IMMUNOGLOBULIN G1;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; ASPARAGUS RACEMOSUS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CELL VACUOLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; GENE REARRANGEMENT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; KIDNEY DISTAL TUBULE; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY STRUCTURE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER PROTECTION; MOUSE; NONHUMAN; PARASITE CLEARANCE; PARASITE LOAD; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; UREA BLOOD LEVEL; VISCERAL LEISHMANIASIS; ANIMAL CELL; ANIMAL MODEL; ANTILEISHMANIAL ACTIVITY; CELL DIFFERENTIATION; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; KUPFFER CELL; LEISHMANIA DONOVANI; LIVER TOXICITY; MALE; NEPHROTOXICITY; PROTEIN EXPRESSION; TH2 CELL;

ASPARAGUS RACEMOSUS; LEISHMANIA DONOVANI; MUS;

ASPARAGUS RACEMOSUS; CISPLATIN; IMMUNOMODULATORY; LEISHMANIA DONOVANI; TREATMENT; VISCERAL LEISHMANIASIS;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIPROTOZOAL AGENTS; ASPARAGUS PLANT; CISPLATIN; DRUG SYNERGISM; IMMUNOGLOBULIN G; IMMUNOMODULATION; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MICE;

EID: 84886016576     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2013.09.016     Document Type: Article

References (34)

1. Paila Y.D., Saha B., Chattopadhyay A. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Biochem Biophys Res Commun 2010, 399:429-433.
2. den Boer M.L., Alvar J., Davidson R.N., Ritmeijer K., Balasegaram M. Developments in the treatment of visceral leishmaniasis. Expert Opin Emerg Drugs 2009, 14:395-410.
3. Seifert K., Croft S.L. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. Antimicrob Agents Chemother 2006, 50:73-79.
4. Meheus F., Balasegaram M., Olliaro P., Sundar S., Rijal S., Faiz M.A. Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis 2010, 4(9):e818.
5. Bogdan C. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol 2008, 10(6):1221-1234.
6. Murray H.W., Lu C.M., Mauze S., Freeman S., Moreira A.L., Kaplan G., et al. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect Immun 2002, 70:6284-6293.
7. Gama M.E.J., Costa M.L., Pereira J.C.R., Gomes C.M.C., Corbett C.E.P. Serum cytokine profile in the subclinical form of visceral leishmaniasis. Braz J Med Biol Res 2004, 37:129-136.
8. Murray H.W. Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother 2001, 45:2185-2197.
9. Einhorn L.H. Curing metastatic testicular cancer. Proc Natl Acad Sci U S A 2002, 99:4592-4595.
10. Tavaers J., Quaissi M., Quaissi A., Cordeiro-da-Silva A. Characterization of anti-Leishmania effect induced by cisplatin: an anticancer drug. Acta Trop 2007, 103:133-141.
11. Kaur S., Sachdeva H., Dhuria S., Sharma M., Kaur T. Antileishmanial effect of cisplatin against murine visceral leishmaniasis. Parasitol Int 2010, 59:62-69.
12. Sharma M., Sehgal R., Kaur S. Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis. PLoS Negl Trop Dis 2012, 6(5):e1629.
13. Shao Y., Chin C.K., Ho C.T., Ma W., Garrison S.A., Huang M.T. Anti-tumor activity of the crude saponins obtained from asparagus. Cancer Lett 24 1996, 104(1):31-36.
14. Shimoyamada M., Suzuki M., Sonta H., Maruyama M., Okubo K. Antifungal activity of the saponin fraction obtained from Asparagus officinalis L. and its active principle. Agric Biol Chem 1990, 54:2553-2557.
15. Thatte U.M., Dahanukar S.A. Immunotherapeutic modification of experimental infections by Indian medicinal plants. Phytother Res 1989, 3:43-49.
16. Kamat J.P., Boloor K.K., Devasagayam T.P., Venkatachalam S.R. Antioxidant properties of Asparagus racemosus against damage induced by gamma-radiation in rat liver mitochondria. J Ethnopharmacol 2000, 71(3):425-435.
17. Sharma P., Chauhan P.S., Dutt P., Amina M., Suri K.A., Dhar K.L. A unique immunostimulant steroidal sapogenin acid from the roots of Asparagus racemosus. Steroids 2010, 76:358-364.
18. Uma B., Prabhakar K., Rajendran S. Anticandidal activity of Asparagus racemosus. Indian J Pharm Sci 2009, 71:342-343.
19. Bradley D.J., Kirkley J. Regulation of Leishmania populations within host. I. The variable course of Leishmania donovani infections in mice. Clin Exp Immunol 1977, 30(1):119-129.
20. Park A.Y., Hondowicz B.D., Scott P. IL-12 is required to maintain a Th-1 response during Leishmania major infection. J Immunol 2000, 165:896-902.
21. Kaur T., Sobti R.S., Kaur S. Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in BALB/c mice. Parasite Immunol 2011, 33:95-103.
22. Berger B.J., Fairlamb A.H. Interactions between immunity and chemotherapy in the treatment of trypanosomiases and leishmaniases. Parasitology 1992, 105:S71-S78.
23. Belkaid Y.K., Hoffmann F., Mendez S., Kamhawi S., Udey M.C., Wynn T.A., et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001, 194:1497-1506.
24. Dutta A., Ghoshal A., Mandal D., Mondal N.B., Banerjee S., Sahu N.P., et al. Racemoside A, an anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani. J Med Microbiol 2007, 56:1196-1204.
25. Basak S.K., Saha B., Bhattacharya A., Roy S. Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation. Eur J Immunol 1992, 22(8):2041-2045.
26. Bhattacharjee S., Gupta G., Bhattacharya P., Adhikari A., Majumdar S.B., Majumdar S. Anti IL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide. Indian J Exp Biol 2009, 47:489-497.
27. Kuby J. Immunology 2007, WH freeman and Company, New York, USA. 5th ed.
28. Grimaldi G., Tesh R.B. Leishmaniases of the new world: current concepts and implications for future research. Clin Microbiol Rev 1993, 6:230-250.
29. Gautam M., Saha S., Bani S., Kaul A., Mishra S., Patil D., et al. Immunomodulatory activity of Asparagus racemosus on systemic Th1/Th2 immunity: implications for immunoadjuvant potential. J Ethnopharmacol 2009, 121(2):241-247.
30. Gautam M., Diwanay S., Gairola S., Shinde Y., Patki P., Patwardhan B. Immunoadjuvant potential of Asparagus racemosus aqueous extract in experimental system. J Ethnopharmacol 2004, 91(2-3):251-255.
31. Annie S., Rajagopal P.L., Malini S. Effect of Cassia fistula Linn. Root extract on cisplatin and gentamicin induced renal injury. Phytomedicine 2005, 555-560.
32. Ajith T.A., Usha S., Nivitha V. Ascorbic acid and α-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta 2007, 375:82-86.
33. Atessahin A., Yilmaz S., Karahan I., Caribasi A.O., Karaoglu A. Effects of lycopene against cisplatin induced nephrotoxicity and oxidative stress in rats. Toxicology 2005, 212:116-123.
34. Acharya S.R., Acharya N.S., Bhangale J.O., Shah S.K., Pandya S.S. Antioxidant and hepatoprotective action of Asparagus racemosus wild root extracts. Indian J Exp Biol 2012, 50:795-801.